Pulse Biosciences targets early October enrollment completion for 164-patient NANOPULSE-AF study (NASDAQ:PLSE)
Pulse BiosciencesPulse Biosciences(US:PLSE) Seeking Alpha·2026-08-07 17:45

根据提供的文档内容，无法提取任何与公司、行业相关的有效信息文档内容仅包含浏览器技术提示，要求启用Javascript和cookies并关闭广告拦截器，未涉及任何投资分析所需的数据、事件或观点

Pulse Biosciences targets early October enrollment completion for 164-patient NANOPULSE-AF study (NASDAQ:PLSE) - Reportify